DARE
Dare Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.77
+3.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 6.44x
- P/S forward
- 2.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -27.06x
- Price / sales
- 11.10x
- Price / cash flow
- -1.34x
Enterprise value
- Enterprise value
- $9.3M
- EV / sales
- 6.81x
- EV / EBITDA
- -1.01x
- EV / EBIT
- -0.84x
- Market cap
- $15.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026